产品封面图

PD-L2蛋白,Recombinant Human PD-L

2 Fc
收藏
  • ¥1900
  • peprotech
  • 310-38
  • 2025年12月06日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 英文名

      Recombinant Human PD-L2 Fc

    • 供应商

      研卉生物

    • 规格

      10ug

    PD-L2蛋白,Recombinant Human PD-L2 Fc

    Product Details

    Catalog Number: 310-38
    Description:

    Programmed death-ligand 2 (PD-L2), or B7-DC, is a member of the B7 ligand family within the immunoglobulin superfamily that, along with programmed death-ligand 1 (PD-L1), acts as a ligand for programmed cell death protein 1 (PD-1). Though expressed primarily in dendritic cells, PD-L2 expression can be induced on a wide variety of immune and non-immune cells depending on the microenvironment. PD-L2 expression is particularly upregulated in the presence of Th2 cytokine, IL-4, as well as Th1 cytokines, TNF-α and IFN-γ to a lesser degree. While generally expressed at lower levels compared to PD-L1, PD-L2 demonstrates a 2 to 6 times higher relative affinity to PD-1 than PD-L1. PD-1 and its ligands are referred to as inhibitory immune checkpoint molecules in that they provide useful negative feedback during physiological homeostasis. Ligation of PD-L2 or PD-L1 inhibits activation, proliferation, and cytokine secretion (e.g. IFN-gamma, IL-10) in T cells, ultimately dampening immune response. Conversely, studies have shown that PD-L2 can also stimulate T-cell proliferation and cytokine production, even in PD-1-deficient T cells, suggesting additional receptors. Recent studies have concluded that PD-L2 also binds to a second receptor, repulsive guidance molecule b (RGMb), which was originally identified as a receptor for bone morphogenetic proteins (BMPs). RGMb is expressed in the central nervous system, as well as in macrophages, however, its role in immunity is only beginning to emerge. Interaction between PD-L2 and RGMb regulates the development of respiratory tolerance in the lung through BMP and/or neogenin signaling pathways. The naturally occurring human PD-L2 monomer consists of a 201-amino-acid extracellular domain, a 21-amino-acid transmembrane domain, and a 32-amino-acid cytoplasmic domain. PeproTech’s CHO cell-derived Recombinant Human PD-L2 Fc is a glycosylated, disulfide-linked homodimer of 433-amino-acid residues whose monomer consists of a 200-amino-acid portion of mature PD-L2, including Leu20 through Pro219, fused to the 231-amino-acid length Fc portion of human IgG1 by two glycines. The calculated molecular weight of monomeric CHO cell-derived Recombinant Human PD-L2 Fc is 48.6 kDa; however, due to glycosylation, it migrates at an apparent molecular weight of approximately 65-75 kDa by SDS-PAGE analysis under reducing conditions.

    Source: CHO cells

     

     

    Synonyms: Programmed cell death 1 ligand 2 (PDCD1 ligand 2), PD-1 ligand 2, Programmed death ligand 2, Butyrophilin B7-DC, CD273, PDCD1LG2, PDCD1L2, PDLB7DC

     

     

    AA Sequence (monomer): LFTVTVPKEL YIIEHGSNVT LECNFDTGSH VNLGAITASL QKVENDTSPH RERATLLEEQ LPLGKASFHI PQVQVRDEGQ YQCIIIYGVA WDYKYLTLKV KASYRKINTH ILKVPETDEV ELTCQATGYP LAEVSWPNVS VPANTSHSRT PEGLYQVTSV LRLKPPPGRN FSCVFWNTHV RELTLASIDL QSQMEPRTHP GGPKSCDKTH TCPPCPAPEL LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS RDELTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK

     

     

    Purity: ≥ 95% by SDS-PAGE gel and HPLC analyses.

    PD-L2文献参考:https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=PD-L2
     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 3 分钟 get 大热的 PD-L1 免疫疗法

      ,患者更可能从中获益。因此对于癌症患者而言,如果 PD-L1 的表达水平较高,则使用 PD 抑制剂的疗效更为显著。目前的临床结果也印证了这一推测(图 3,4)。正因为如此,PD 抑制剂药物的使用,大多需要伴随 / 补充诊断检测 PD-L1 的表达,而 PD-L1 的检测方法主要是基于蛋白水平的免疫组化。那么为什么不选择检测 PD-1 呢?在使用抗 PD-1 抑制剂的条件下,PD-1 水平通常不会发生变化,此时检测 PD-L1 可以反映没有结合的 PD-L1 水平,从而反映药物的作用程度。而 PD-L

    • 「神药」再显威!杨黄浩等让二甲双胍扮演 PD-L1 「单抗」角色,提高治疗效果

      学者 Mien-Chie Hung 团队发现 [2],长期服用二甲双胍的乳腺癌患者,其肿瘤组织的 PD-L1 表达水平较低。进一步深入研究后发现,二甲双胍直接激活了 AMPK,后者直接介导了 PD-L1 中 S195 的磷酸化。S195 磷酸化导致 PD-L1 糖基化异常,异常的 PD-L1 通过内质网相关蛋白降解(ERAD)途径降解,降低了 PD-L1 的表达水平。二甲双胍阻断 PD-1/PD-L1 信号轴可增强 CTL 对癌细胞的杀伤活性。 图片来源:Molecular Cell 2、 二甲双胍的「星星

    • Quantification of Human IgG and Related Fc Fusion Proteins by a Human IgG/Fc Capture ELISA

      of recombinant human IgGs after production and purification for further assays. Here, we describe a human IgG/Fc capture enzyme linked immunosorbent assay (ELISA) which is simple, robust, inexpensive and specific for all types of human IgGs and related Fc fusion

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2730
    北京百普赛斯生物科技股份有限公司
    2026年02月17日询价
    ¥2600
    北京百奥创新科技有限公司
    2026年04月01日询价
    ¥2980
    北京义翘神州科技股份有限公司(Sino Biological Inc.)
    2026年01月26日询价
    ¥3500
    上海研卉生物科技有限公司
    2025年08月24日询价
    ¥2200
    青木生物技术(武汉)有限公司
    2026年02月26日询价
    PD-L2蛋白,Recombinant Human PD-L2 Fc
    ¥1900